Stock Events

Stock Events

Arbutus Biopharma (0SGC.LSE) Q4 2023 Earnings

29FebConfirmed

Q4 2023

-0.12

-0.12

-0.12

-0.12

Details

Expected EPS

-0.116

Actual EPS

-0.12

Surprise EPS

-0

Surprise Percent

+3.45%

Description

Arbutus Biopharma (0SGC.LSE) has reported earnings of -0.12 per share for Q4 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.